Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Security class unavailable · CUSIP: 00773U108

Event date: 2024-02-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,000,000
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000243
Form type
SC 13G
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Feb 22, 2024
Reporting period
Feb 06, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub